Compare Aehr Test Systems (AEHR) vs Payoneer Global Inc (PAYO) Price & Performance

AEHR Test Systems (AEHR) surged 25.02% to $132.77, driven by strong earnings beats and a $22 million follow-on order for AI processor wafer-level burn-in systems (Accesswire, August 12, 2026). The stock exhibits bullish technical signals with support at $112 and resistance at $129, though RSI suggests overbought conditions. Revenue reached $58.97 million in 2025, but net income remained negative at -$3.91 million, reflecting high growth investments.

Outlook is optimistic due to AI and silicon photonics demand, with FY27 revenue growth projected at 160–200% (Seeking Alpha, July 18, 2026). Risks include customer concentration and negative cash flow. Analysts are mixed (33% buy, 67% hold), highlighting valuation concerns at a P/S of 71.87. Upside potential exists if execution aligns with backlog growth.

PAYO trades at $7.095, up 0.07% today, near its 52-week high of $7.67. The stock shows a bullish technical signal with moving averages supporting upside, while oscillators are neutral. Recent Q2 2026 earnings missed estimates at $0.02 per share versus $0.06 expected, though revenue grew 10% year-over-year. The pending acquisition by Nuvei for $7.40 per share, announced June 15, 2026, anchors the price near deal terms, with legal inquiries ongoing regarding fairness.

Outlook is acquisition-driven with limited upside to the $7.40 offer, posing a 4.3% gain from current levels. Risks include deal completion uncertainty and earnings volatility, while opportunities lie in potential bid revisions. Analysts maintain a 60% buy rating with an $8.20 consensus target, suggesting confidence in long-term value beyond the takeover.